News

< Back to Heads UP Podcast

Heads UP – Episode 103: Atogepant and Migraine

Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention?

No Comments

Sorry, the comment form is closed at this time.

Subscribe to our Monthly e-Newsletter

Gain access to the most current migraine and headache information, prevention,

treatment, research, and news.